CSL (ASX:CSL) share price pops on increased dividend

The CSL (ASX: CSL) share price is higher today after the biotech announced a dramatic lift in profits and boosted dividend for the half-year.

| More on:
medical asx share price represented by doctor giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Ltd (ASX: CSL) shares are trending higher in early trade today following the release of the pharmaceutical giant's half-year results. At the time of writing the CSL share price is 2.38% higher at $287.89.

Profits in tip-top shape

All eyes were on the CSL share price this morning following the release of the company's results. Fortunately, the numbers did not disappoint, sending CSL shares higher in morning trade.

The most exhilarating number to come out of the half-year report was the company's bumper profit. Due to increased margins, CSL managed to deliver a 45% increase to its reported net profit after tax of US$1,810 million.

Additionally, CSL's revenue grew to US$5,739 million. Although not as substantial an increase in percentage terms, at 16.9%, the top-line growth is significant. The driving force behind the increase was a 9% lift in CSL Behring revenue and a 38% jump in Seqirus revenue.

Importantly, it appears the business segment responsible for the seasonal flu vaccine has contributed largely to the result. Seqirus added US$693 million to earnings before interest and tax – an increase of 112%.

Increased CSL dividend

As a result of the strong numbers, the CSL board increased the interim dividend by 9% to US$1.04 per share. Unfortunately, the weak US dollar to AUD means this payout is 9% lower than the prior corresponding period on a constant currency basis.

By chief executive officer and managing director Paul Perreault's account, the future for CSL remains rosy: "Demand for CSL's core plasma, and influenza vaccine products remain robust."

However, there is expected to be a lift in costs in the next half as the biotech builds its research up again, after falling due to COVID-19 vaccine development efforts.

CSL share price under the microscope

The CSL share price has taken a beating over the last year, down by around 13%. COVID-19 disruptions and vaccine development efforts weighed on the business and its usual operations.

However, in the last month, the share price has experienced a reasonable 7.6% lift as some geographies return to normal.

Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two woman shopping and pointing at a bargain opportunity.
52-Week Lows

Bargain hunting – these ASX shares are trading near 52-week lows

Looking for a bargain buy?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Wednesday

A good session is expected for Aussie investors on hump day.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

2 unmissable ASX 300 shares that look too cheap to ignore!

I strongly believe these businesses are substantially undervalued.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

2 compelling ASX shares I'd buy in a heartbeat

These investments have great potential to deliver good returns…

Read more »

happy new financial year represented by fireworks
Best Shares

My 10 top stocks to buy to start the New Year off right

I think these ten stocks are primed for 2026.

Read more »

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Fortescue, Qantas, and WiseTech shares

Are these popular shares in the buy zone? Let's find out what analysts are saying.

Read more »

Woman attached to rocket flies into the air
52-Week Highs

Scores of ASX mining shares hit 52-week highs

BHP, Rio Tinto, South32, and Mineral Resources shares are among those that hit 52-week highs today.

Read more »